Alimera Sciences, Inc. (ALIM)

Alimera Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	14.35	12.09	5.3	16.54	11.24	9.46
Cash & Cash Equivalents	14.35	12.09	5.3	16.54	11.24	9.46
Cash Growth	9.37%	127.94%	-67.94%	47.16%	18.85%	-27.66%
Receivables	34.22	34.55	19.61	19.13	17.2	19.33
Inventory	2.21	1.88	1.61	2.68	2.75	1.39
Other Current Assets	3.69	3.91	2.89	3.81	3.72	2.57
Total Current Assets	54.47	52.42	29.41	42.16	34.91	32.75
Property, Plant & Equipment	3.44	3.59	3.92	4.49	2.36	2.05
Goodwill and Intangibles	94.47	97.36	8.96	10.9	12.84	14.78
Other Long-Term Assets	0.11	0.16	0.31	0.97	0.75	0.73
Total Long-Term Assets	98.02	101.1	13.19	16.36	15.95	17.56
Total Assets	152.49	153.52	42.6	58.52	50.86	50.31
Accounts Payable	10.31	8.25	10.09	8.71	7.46	7.08
Current Debt	0.22	0.19	25.65	0.27	1.69	0.26
Other Current Liabilities	10.26	13.47	4	3.62	3.2	4.72
Total Current Liabilities	20.79	21.91	39.73	12.59	12.35	12.05
Long-Term Debt	69.44	64.49	18.68	43.08	42.41	38.75
Other Long-Term Liabilities	21.61	20.95	5	5.45	4.08	3.95
Total Long-Term Liabilities	91.04	85.44	23.68	48.53	46.49	42.71
Total Liabilities	111.83	107.35	63.41	61.13	58.83	54.75
Total Debt	69.66	64.68	44.33	43.35	44.1	39.01
Debt Growth	56.83%	45.92%	2.26%	-1.70%	13.05%	1.54%
Retained Earnings	-424.74	-418.49	-415.39	-397.28	-392.91	-387.57
Comprehensive Income	-2.85	-2.71	-2.96	-1.85	-0.55	-1.09
Shareholders' Equity	40.65	46.17	-20.81	-2.61	-7.98	-4.45
Net Cash / Debt	-55.31	-52.59	-39.03	-26.81	-32.86	-29.55
Net Cash Per Share	-1.02	-2.06	-5.58	-4.06	-6.42	-6.19
Working Capital	33.68	30.51	-10.32	29.57	22.56	20.7
Book Value Per Share	0.75	1.81	-2.97	-0.40	-1.56	-0.93

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).